{
    "2021-04-09": [
        [
            {
                "time": "2021-03-01",
                "original_text": "FIDELITY INVESTMENT TRUST增持泰格医药(03347)约12.51万股，每股作价约154.16港元",
                "features": {
                    "keywords": [
                        "FIDELITY INVESTMENT TRUST",
                        "增持",
                        "泰格医药",
                        "港股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "两市百元股数量达134只，医药生物行业占比最高",
                "features": {
                    "keywords": [
                        "百元股",
                        "医药生物",
                        "行业占比"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "泰格医药(300347)：子公司购股权计划 深度激发员工活力",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "子公司",
                        "购股权计划",
                        "员工活力"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "北上资金全透视月报(21年3月)：上月外资继续流入 增持金融与周期",
                "features": {
                    "keywords": [
                        "北上资金",
                        "外资流入",
                        "金融",
                        "周期"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "周期"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "泰格医药(300347)2020年报点评：疫情恢复良好 在手订单提速",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "2020年报",
                        "疫情恢复",
                        "订单提速"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "高瓴资本概念股走势分化，恩捷股份、公牛集团、良品铺子、泰格医药下滑",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "概念股",
                        "走势分化",
                        "泰格医药",
                        "下滑"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "其他"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "“医药女神”葛兰最新持股曝光：2020年减持10股 减持股份",
                "features": {
                    "keywords": [
                        "医药女神",
                        "葛兰",
                        "减持",
                        "持股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "受益于国内创新药开发投入增加，CRO企业财报亮眼",
                "features": {
                    "keywords": [
                        "创新药",
                        "开发投入",
                        "CRO企业",
                        "财报亮眼"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "泰格医药(03347.HK)获FIDELITY INVESTMENT TRUST增持12.51万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "FIDELITY INVESTMENT TRUST",
                        "增持"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}